Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 201

Similar articles for PubMed (Select 19516033)

1.

The safety of metoclopramide use in the first trimester of pregnancy.

Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A.

N Engl J Med. 2009 Jun 11;360(24):2528-35. doi: 10.1056/NEJMoa0807154.

2.

First epidemiological data for venotonics in pregnancy from the EFEMERIS database.

Lacroix I, Beau AB, Hurault-Delarue C, Bouilhac C, Petiot D, Vayssière C, Vidal S, Montastruc JL, Damase-Michel C.

Phlebology. 2015 Jun 9. pii: 0268355515589679. [Epub ahead of print]

PMID:
26060062
3.

Trends and Determinants of Prescription Drug Use during Pregnancy and Postpartum in British Columbia, 2002-2011: A Population-Based Cohort Study.

Smolina K, Hanley GE, Mintzes B, Oberlander TF, Morgan S.

PLoS One. 2015 May 26;10(5):e0128312. doi: 10.1371/journal.pone.0128312. eCollection 2015.

4.

Triptans during pregnancy.

[No authors listed]

Prescrire Int. 2014 Oct;23(153):244. Review. No abstract available.

PMID:
25964975
5.

Exposure to topical chloramphenicol during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study.

Thomseth V, Cejvanovic V, Jimenez-Solem E, Petersen KM, Poulsen HE, Andersen JT.

Acta Ophthalmol. 2015 Apr 28. doi: 10.1111/aos.12737. [Epub ahead of print]

PMID:
25923453
6.

Use and Safety of Erythromycin and Metoclopramide in Hospitalized Infants.

Ericson JE, Arnold C, Cheeseman J, Cho J, Kaneko S, Wilson E, Clark RH, Benjamin DK Jr, Chu V, Smith PB, Hornik CP; Best Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee.

J Pediatr Gastroenterol Nutr. 2015 Mar 21. [Epub ahead of print]

PMID:
25806675
7.

Use of ondansetron during pregnancy and congenital malformations in the infant.

Danielsson B, Wikner BN, Källén B.

Reprod Toxicol. 2014 Dec;50:134-7. doi: 10.1016/j.reprotox.2014.10.017. Epub 2014 Oct 31.

PMID:
25450422
8.

Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester.

Sheeran C, Nicolopoulos J.

Australas J Dermatol. 2014 Aug;55(3):235-6. doi: 10.1111/ajd.12214. No abstract available.

PMID:
25117169
9.

First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study.

Ban L, West J, Gibson JE, Fiaschi L, Sokal R, Doyle P, Hubbard R, Smeeth L, Tata LJ.

PLoS One. 2014 Jun 25;9(6):e100996. doi: 10.1371/journal.pone.0100996. eCollection 2014.

10.

Safety of cotrimoxazole in pregnancy: a systematic review and meta-analysis.

Ford N, Shubber Z, Jao J, Abrams EJ, Frigati L, Mofenson L.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):512-21. doi: 10.1097/QAI.0000000000000211. Review.

11.

[Drug in pregnancy: studies in the French database EFEMERIS].

Damase-Michel C, Lacroix I, Hurault-Delarue C, Beau AB, Montastruc JL; les partenaires d’EFEMERIS.

Therapie. 2014 Jan-Feb;69(1):91-100. doi: 10.2515/therapie/2014005. Epub 2014 Apr 4. French.

PMID:
24698193
12.

Pregnancy outcome in women exposed to dopamine agonists during pregnancy: a pharmacoepidemiology study in EFEMERIS database.

Hurault-Delarue C, Montastruc JL, Beau AB, Lacroix I, Damase-Michel C.

Arch Gynecol Obstet. 2014 Aug;290(2):263-70. doi: 10.1007/s00404-014-3210-z. Epub 2014 Mar 25.

PMID:
24664257
13.

The fetal safety of Levetiracetam: a systematic review.

Chaudhry SA, Jong G, Koren G.

Reprod Toxicol. 2014 Jul;46:40-5. doi: 10.1016/j.reprotox.2014.02.004. Epub 2014 Mar 3. Review.

PMID:
24602560
14.

Assessment of antihistamine use in early pregnancy and birth defects.

Li Q, Mitchell AA, Werler MM, Yau WP, Hernández-Díaz S.

J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):666-74.e1. doi: 10.1016/j.jaip.2013.07.008. Epub 2013 Sep 12.

15.

ACP Journal Club. Metoclopramide during pregnancy did not increase risk for major congenital malformations or fetal death.

Tan PC.

Ann Intern Med. 2014 Feb 18;160(4):JC13. doi: 10.7326/0003-4819-160-4-201402180-02013. No abstract available.

PMID:
24534935
16.

Fetal outcomes associated with metoclopramide use in pregnancy--reply.

Pasternak B, Svanström H, Hviid A.

JAMA. 2014 Feb 12;311(6):624. doi: 10.1001/jama.2013.285289. No abstract available.

PMID:
24519310
17.

Fetal outcomes associated with metoclopramide use in pregnancy.

Vrachnis N, Zygouris D, Iliodromiti Z.

JAMA. 2014 Feb 12;311(6):623-4. doi: 10.1001/jama.2013.285286. No abstract available.

PMID:
24519307
18.

An approach to preventing adverse drug effects during pregnancy.

Prescrire Editorial Staff.

Prescrire Int. 2014 Jan;23(145):24-6. No abstract available.

PMID:
24516911
19.

First-trimester exposure to methylphenidate: a population-based cohort study.

Pottegård A, Hallas J, Andersen JT, Løkkegaard EC, Dideriksen D, Aagaard L, Damkier P.

J Clin Psychiatry. 2014 Jan;75(1):e88-93. doi: 10.4088/JCP.13m08708.

20.

Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions.

Daniel S, Koren G, Lunenfeld E, Bilenko N, Ratzon R, Levy A.

CMAJ. 2014 Mar 18;186(5):E177-82. doi: 10.1503/cmaj.130605. Epub 2014 Feb 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk